Longitudinal Changes in Bone Mineral Density and Trabecular Bone Score in Adolescents With Graves' Disease
Clinical Endocrinology · 2025
DOI: 10.1111/cen.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Pattara Wiromrat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Endocrinology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Bone Density, Graves Disease, Cancellous Bone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: This study was funded by Khon Kaen University, Faculty of Medicine Invitation Research Grant [IN63336]..
Abstract (Originalsprache)
Objective
Longitudinal data on bone health in adolescents with Graves' disease (GD) are limited. Thus, we aimed to evaluate lumbar spine bone mineral density (LSBMD) and trabecular bone score (TBS) changes in this population.
Methods
Baseline and follow‐up LSBMD Z ‐score (LSBMD Z ) and TBS Z ‐score (TBS Z ) were measured. TBS was analysed using iNsight software.
Results
Forty‐one adolescents with GD (age 13.7 ± 2.8 years, 73% female) were enroled. At baseline, 18% of adolescents with recently diagnosed GD (RGD, ≤ 6 months) had low LSBMD (median LSBMD Z : −0.7 [−1.5 to −0.4]), and 58% had low TBS (mean TBS Z : −1.5 ± 1.3). The median follow‐up duration was 2.2 (1.2–2.9) years. In the entire cohort, at follow‐up, LSBMD Z normalized, whereas TBS Z remained below zero ( p = 0.007). Adolescents with RGD and those with longer disease duration had comparable LSBMD Z and TBS Z at follow‐up. When stratified by baseline disease duration tertiles, improvements in LSBMD Z ( p = 0.013) and TBS Z ( p = 0.035) progressively declined with increasing disease duration. LSBMD Z was significantly increased from baseline during 28 months of treatment ( p = 0.01), while TBS Z improvement was observed during the initial 9 months ( p = 0.046). Stepwise regression identified time‐weighted free thyroxine (FT4) as a negative predictor of ∆TBS Z ( p = 0.042).
Conclusions
Low TBS was prevalent among adolescents recently diagnosed with GD. Despite observed improvements, TBS Z remained below zero at follow‐up, indicating incomplete recovery. As FT4 negatively impacts TBS improvement, maintaining optimal FT4 concentrations early in the disease is crucial for preserving bone microarchitecture in paediatric GD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Endocrinology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Department of Radiology, Division of Nuclear Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Epidemiology Unit, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Department of Medicine, Division of Endocrinology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
ORCID-Profile: Pattara Wiromrat
Förderung
- This study was funded by Khon Kaen University, Faculty of Medicine Invitation Research Grant [IN63336].
Zitieren
APA
Wiromrat, P., Wongsurawat, N., Chaisiwamongkol, R., Raruenrom, Y., Suparattanagool, P., Panamonta, O., & Pongchaiyakul, C. (2025). Longitudinal Changes in Bone Mineral Density and Trabecular Bone Score in Adolescents With Graves' Disease. Clinical Endocrinology. https://doi.org/10.1111/cen.70004
Vancouver
Wiromrat P, Wongsurawat N, Chaisiwamongkol R, Raruenrom Y, Suparattanagool P, Panamonta O, et al. Longitudinal Changes in Bone Mineral Density and Trabecular Bone Score in Adolescents With Graves' Disease. Clinical Endocrinology. 2025. doi:10.1111/cen.70004
BibTeX
@article{Wiromrat2025,
author = {Wiromrat, Pattara and Wongsurawat, Nantaporn and Chaisiwamongkol, Ratikorn and Raruenrom, Yutapong and Suparattanagool, Piyanan and Panamonta, Ouyporn and Pongchaiyakul, Chatlert},
title = {Longitudinal Changes in Bone Mineral Density and Trabecular Bone Score in Adolescents With Graves' Disease},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.70004}
}
EUVIMED